Bodnar-horvath Kwai Yung Helen - Net Worth and Insider Trading
Bodnar-horvath Kwai Yung Helen Net Worth
The estimated net worth of Bodnar-horvath Kwai Yung Helen is at least $4.4 Billion dollars as of 2024-06-23. Bodnar-horvath Kwai Yung Helen is the 2202 Interest of your spouse of China Shineway Pharmaceutical Group Ltd and owns about 546,802,990 shares of China Shineway Pharmaceutical Group Ltd (HKSE:02877) stock worth over $4.4 Billion. Details can be seen in Bodnar-horvath Kwai Yung Helen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bodnar-horvath Kwai Yung Helen has not made any transactions after 2021-12-28 and currently still holds the listed stock(s).
Transaction Summary of Bodnar-horvath Kwai Yung Helen
Bodnar-horvath Kwai Yung Helen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bodnar-horvath Kwai Yung Helen owns 1 companies in total, including China Shineway Pharmaceutical Group Ltd (HKSE:02877) .
Click here to see the complete history of Bodnar-horvath Kwai Yung Helen’s form 4 insider trades.
Insider Ownership Summary of Bodnar-horvath Kwai Yung Helen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02877 | China Shineway Pharmaceutical Group Ltd | 2021-12-28 | 2202 Interest of your spouse |
Bodnar-horvath Kwai Yung Helen Latest Holdings Summary
Bodnar-horvath Kwai Yung Helen currently owns a total of 1 stock. Bodnar-horvath Kwai Yung Helen owns 546,802,990 shares of China Shineway Pharmaceutical Group Ltd (HKSE:02877) as of December 28, 2021, with a value of $4.4 Billion.
Latest Holdings of Bodnar-horvath Kwai Yung Helen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02877 | China Shineway Pharmaceutical Group Ltd | 2021-12-28 | 546,802,990 | 8.13 | 4,445,508,309 |
Holding Weightings of Bodnar-horvath Kwai Yung Helen
Bodnar-horvath Kwai Yung Helen Form 4 Trading Tracker
According to the SEC Form 4 filings, Bodnar-horvath Kwai Yung Helen has made a total of 1 transactions in China Shineway Pharmaceutical Group Ltd (HKSE:02877) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in China Shineway Pharmaceutical Group Ltd is the sale of 0 shares on December 28, 2021, which brought Bodnar-horvath Kwai Yung Helen around $0.
Insider Trading History of Bodnar-horvath Kwai Yung Helen
- 1
Bodnar-horvath Kwai Yung Helen Trading Performance
Bodnar-horvath Kwai Yung Helen Ownership Network
Bodnar-horvath Kwai Yung Helen Owned Company Details
What does China Shineway Pharmaceutical Group Ltd do?
Who are the key executives at China Shineway Pharmaceutical Group Ltd?
Bodnar-horvath Kwai Yung Helen is the 2202 Interest of your spouse of China Shineway Pharmaceutical Group Ltd. Other key executives at China Shineway Pharmaceutical Group Ltd include 2301 Trustee Bh Corporate Services Ltd , 2201 Interest of corporation controlled by you Bodnar-horvath Nicholas Eugene Francis , and 2101 Beneficial owner Forway Investment Limited .
China Shineway Pharmaceutical Group Ltd (HKSE:02877) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of China Shineway Pharmaceutical Group Ltd (HKSE:02877) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of China Shineway Pharmaceutical Group Ltd (HKSE:02877) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
China Shineway Pharmaceutical Group Ltd (HKSE:02877)'s detailed insider trading history can be found in Insider Trading Tracker table.
China Shineway Pharmaceutical Group Ltd Insider Transactions
Bodnar-horvath Kwai Yung Helen Mailing Address
Above is the net worth, insider trading, and ownership report for Bodnar-horvath Kwai Yung Helen. Currently GuruFocus does not have mailing address information for Bodnar-horvath Kwai Yung Helen.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
